24 Sep: Uncertainty around TRIPS waiver. 

Editor’s Blog: Produced in collaboration with the EU Buzz team. 

With the debacle surrounding the global race for a vaccine against Covid-19, and the greed of wealthy nations to have it first, the issue of intellectual property rights (IPR) protection, especially relating to health, essential medicines and pharmaceuticals, should be top of the health agenda, and with a caveat, “to be addressed urgently”. Sadly, this is not the case, even in the multilateral fora. 

The World Trade Organization (WTO) Agreement on Trade-related Intellectual Property Rights (TRIPS), is supposed to cover not only intellectual property rights, but also the rights of …